Jill Henrich is the Senior Vice President, Global Regulatory Affairs at Atara Biotherapeutics. She is excited to utilize her more than 20 years of experience in regulatory affairs, as well as her background in research to deliver transformative medicines to patients through her role at Atara.
Jill came to Atara from OncoMed Pharmaceuticals, a wholly owned subsidiary of Mereo BioPharma where she served as U.S. Site Head and Senior Vice President of Regulatory Affairs. Before the merger in 2019, she was Senior Vice President, Regulatory Affairs and Quality, providing oversight on all aspects of global Regulatory Affairs and Quality Assurance strategy, implementation and execution. In her most recent time at OncoMed, Jill successfully negotiated an accelerated approval pathway for a DLL4/VegF bispecific antibody for the treatment of ovarian cancer at an FDA EOP1 meeting and gained agreement from FDA at an EOP2 meeting on the design of a single pivotal pediatric Phase 3 study for patients with osteogenesis imperfecta, a rare disease affecting children. She has led numerous meetings with the EMA and other European regulatory bodies for the setrusumab program through PRIME Designation and Adaptive Pathways. In addition, she was responsible for successfully filing and executing 14 Investigational New Drug (IND) applications for 9 novel programs in oncology.
Prior to joining OncoMed, she served as Executive Director, Regulatory Affairs and Quality Assurance at PDL BioPharma, Inc. providing strategic management and oversight for all regulatory interactions, Regulatory Operations/Corporate Document Control, Medical Writing and QA/Compliance activities. Jill also held a similar role at Corixa Corporation (formerly Coulter Pharmaceutical, Inc.) where she was instrumental in the filing and approval of an iodine-131 radiolabeled anti-CD20 monoclonal antibody for the treatment of non-Hodgkin’s lymphoma. In addition, she has held various positions in Research (Cell Genetics/Molecular Biology) and Regulatory Affairs at Genentech, where she maintained global regulatory responsibility for two approved marketed products and multiple products in various phases of development.
Jill holds a B.S. in Biological Sciences/Microbiology from the University of Connecticut.
In her free time, Jill enjoys the outdoors and is an avid mountain and road biker and hiker. She has also recently taken up bread baking.
Sign up to view 3 direct reports
Get started